Series B - CG Oncology
Investment Firm
Overview
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Announced Date
May 23, 2023
Funding Type
Series B
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
CG Oncology raised an undisclosed amount on 2023-05-23 in Series B
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 02, 2023 |  Series F - CG Oncology | 11 | - | 105.0M |
| May 23, 2023 | Series B - CG Oncology | 1 | - | undefined |
| Aug 05, 2015 | Series B - CG Oncology | 4 | - | 10.0M |
| Jul 29, 2014 | Series A - CG Oncology | 2 | - | 13.6M |
Recent Activity
There is no recent news or activity for this profile.